Skip to main content

Meet us

  • Virtuell

    R&D-Webinar Heidelberg Pharma

    23. April
  • Conference

    PEGS Boston 2024

    13. - 17. Mai
  • Panel, presentation

    ASCO - American Society of Clinical Oncology - Annual Meeting

    31. Mai - 4. Juni
  • Panel, presentation

    10th Annual Oncology Innovation Forum

    31. Mai

    Upcoming Conferences & Presentations 2024

    EventDateLocationPresentation (local time)
    Deutsche Biotechnologietage
    16. - 17. April
    Berlin
    Kempen Life Science Conference
    16. - 17. April
    Amsterdam
    R&D-Webinar Heidelberg Pharma
    23. April
    16:00 Uhr MESZ/15:00 Uhr BST
    PEGS Boston 2024
    13. - 17. Mai
    Boston
    ASCO - American Society of Clinical Oncology - Annual Meeting
    31. Mai - 4. Juni
    Chicago
    10th Annual Oncology Innovation Forum
    31. Mai
    Chicago
    BIO International Convention 2024
    3. - 6. Juni
    San Diego
    Antibody Engineering & Therapeutics Europe
    4. - 6. Juni
    London
    World ADC Asia
    25. - 27. Juni
    Seoul
    GRC Natural Products and Bioactive Compounds
    28. Juli - 2. August
    Andover
    EPS (European Peptide Symposium)
    25. - 30. August
    Florence
    International Symposium on Medicinal Chemistry
    1. - 5. September
    Rom
    BIO Japan
    9. - 11. Oktober
    Yokohama
    Festival of Biologics
    15. - 17. Oktober
    Basel
    HUPO World Congress
    20. - 24. Oktober
    Dresden
    Annual World ADC San Diego
    4. - 7. November
    San Diego
    PEGS Europe
    5. - 7. November
    Barcelona
    ASH Annual Meeting and Exposition
    7. - 10. Dezember
    San Diego

    Past Conferences & Presentations 2024

    EventDateLocation
    AACR Annual Meeting 2024
    5. - 10. April
    San Diego
    Jeffries Pan European Mid-Cap Conference
    19. - 21. März
    London
    BIO-Europe Spring
    18. - 20. März
    Barcelona
    World ADC
    12. - 15. März
    London
    Biomarkers 2024
    29. Februar - 1. März
    London

    Current Company Presentation, Feb 2024

    Presentations are archived information about Heidelberg Pharma AG and were current at the time they were published. Archived information may have been replaced by more recent information published by the company in more recent presentations, press releases or elsewhere. The presentations and recordings may contain forward-looking statements based on management's beliefs as of the date of publication. Actual developments may differ materially from the information contained in the publications due to various factors.